Lung cancer: open trials in China

• NCT05920356

  A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  Trial Treatment · Phase 3 · Amgen

  Anyang Tumor Hospital, Anyang · Affiliated Hospital of Hebei University, Baoding · Beijing chest hospital, Capital Medical University, Beijing · Peking Union Medical College Hospital, Beijing · Beijing Cancer Hospital, Beijing · The First Affiliated Hospital of Bengbu Medical University, Bengbu · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital, Changsha · Xiangya Hospital Central South University, Changsha · The Second Xiangya Hospital of Central South University, Changsha · West China Hospital，Sichuan University, Chengdu · Sichuan Cancer Hospital, Chengdu · Chongqing University Cancer Hospital, Chongqing · Fujian Cancer Hospital, Fuzhou · Fujian Medical University Union Hospital, Fuzhou · Fujian Provincial Hospital, Fuzhou · Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou · Guangdong Provincial Peoples Hospital, Guangzhou · Hainan Cancer Hospital, Haikou · Sir Run Run Shaw Hospital Affiliated to Zhejiang University School of Medicine, Hangzhou · Zhejiang Cancer Hospital, Hangzhou · The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Anhui Chest Hospital, Hefei · Cancer Hospital of Shandong First Medical University, Jinan · Yunnan Cancer Hospital, Kunming · Gansu Province Cancer Hospital, Lanzhou · Linyi Peoples Hospital, Linyi · Liuzhou Peoples Hospital, Liuzhou · The First Affiliated Hospital of Henan University of Science and Technology, Luoyang · Jiangxi Cancer Hospital, Nanchang · The First Affiliated Hospital of NanChang University, Nanchang · Nanjing Drum Tower hospital, Nanjing · Nanjing First Hospital, Nanjing · Guangxi Medical University Cancer Hospital, Nanning · Nantong Tumor Hospital, Nantong · Fudan University Shanghai Cancer Center, Shanghai · Cancer Hospital of Shantou University Medical College, Shantou · Shanxi Cancer hospital, Taiyuan · Taizhou Hospital of Zhejiang Province, Taizhou · Tianjin Medical University Cancer Institute and Hospital, Tianjin · Weifang Peoples Hospital, Weifang · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Tongji Hospital Tongji Medical College of Hust, Wuhan · The First Affiliated hospital of Xiamen University, Xiamen · Zhongshan Hospital Xiamen University, Xiamen · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Xiangyang Central Hospital, Xiangyang · The First Affiliated Hospital of Zhengzhou University, Zhengzhou · Henan Cancer Hospital, Zhengzhou

  Registry updated 2026-11-06

• NCT06422546

  A Prospective ,Multicenter ,Non-interventional ,Real-world Study Observing Changes in Molecular Markers Osimertinib Targeted Therapy in EGFRm NSCLC

  Research · Beijing Cancer Prevention & Treatment Society

  Cancer Hospital Chinese, Beijing

  Registry updated 2026-11-06

• NCT07830095

  5G-Enabled Remote Robotic-Assisted Bronchoscopy-Guided Cryoablation for Pulmonary Malignancies

  Trial Treatment · Shanghai Chest Hospital

  Shanghai Chest Hospital, Shanghai

  Registry updated 2026-11-06

• NCT07874282

  Phase II Study to Evaluate Telisotuzumab Adizutecan in Combination With RC148(ABBV-1480) as First-Line Treatment for Patients With Non-Squamous Non-Small-Cell Lung Cancer

  Trial Treatment · Phase 2 · RemeGen Co., Ltd.

  Shanghai East Hospital, Tongji University School of Medicine, Shanghai

  Registry updated 2026-11-06

• NCT07920822

  Evaluation of the I-phase Clinical Trial of 177Lu-HX02 Injection in Patients With Advanced Malignant Solid Tumors

  Trial Treatment · Phase 1 · Hexin (Suzhou) Pharmaceutical Technology Co., Ltd

  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

  Registry updated 2026-11-06

• NCT05789082

  A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

  Trial Treatment · Phase 1/2 · Hoffmann-La Roche

  Hunan Cancer Hospital, Changsha · Harbin Medical University Cancer Hospital, Harbin · Shanghai Pulmonary Hospital, Shanghai

  Registry updated 2026-11-05

• NCT06793215

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  Trial Treatment · Phase 3 · Hoffmann-La Roche

  Beijing Cancer Hospital, Beijing · The First Affiliated Hospital of Bengbu Medical College, Bengbu · The Second Xiangya Hospital of Central South University, Changsha · Hunan Cancer Hospital, Changsha · West China Hospital，Sichuan University, Chengdu · The First Affilicated Hospital, Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University, Hangzhou · The First Affiliated Hospital, Zhejiang University School of Medicine - Qingchun Campus - PPDS, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Anhui Provincial Hospital(The First Affiliated Hospital of Ustc), Hefei · Shandong Cancer Hospital, Jinan · Yunnan Cancer Hospital, Kunming · The First Affiliated Hospital of NanChang University, Nanchang · Nantong Tumor Hospital, Nantong · Shanghai East Hospital, Shanghai · Shanghai Pulmonary Hospital, Shanghai · Fudan University Shanghai Cancer Center, Shanghai · Tumor Hospital of the affiliated medical college of Shantou University, Shantou · Hubei Cancer Hospital, Wuhan

  Registry updated 2026-11-05

• NCT06862869

  Real World Clinical Outcomes of Resected ALK-Positive Early Stage NSCLC Patients Treated With Alectinib as Adjuvant Therapy

  Research · Hoffmann-La Roche

  Peking University First Hospital, Beijing · Xuanwu Hospital, Capital Medical University, Beijing · Hunan Cancer Hospital, Changsha · Changzhou First People's Hospital, Changzhou · Sichuan Academy of Medical Sciences and Sichuan Provincial Peoples Hospital, Chengdu · The First Affiliated Hospital, Chongqing Medical University, Chongqing · The Second Affiliated Hospital of Dalian Medical University, Dalian · Fujian Cancer Hospital, Fuzhou · Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · The Second Affiliated Hospital, Zhejiang University, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Anhui Provincial Hospital, Hefei · Huzhou Central Hospital, Huzhou · Jiangmen Central Hospital, Jiangmen · Shandong Provincial Hospital, Jinan · Huai He Hospital of Henan University, Kaifeng · Lanzhou University Second Hospital, Lanzhou · The First Affiliated Hospital of NanChang University, Nanchang · Jiangsu Province Hospital, Nanjing · Jiangsu Cancer Hospital, Nanjing · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Affiliated Hospital of Nantong University, Nantong · Ningbo No.2 Hospital, Ningbo · Zhongshan Hospital,Fudan University, Shanghai · Shanghai Pulmonary Hospital, Shanghai · Shanghai Chest Hospital, Shanghai · Liaoning Provincial Cancer Hospital, Shengyang · Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center, Shenzhen · Hebei Medical University Fourth Hospital, Shijiazhuang · Shanxi Provincial Cancer Hospital, Taiyuan · Taizhou Hospital of Zhejiang Province, Taizhou · Chest disease hospital of Tianjin City, Tianjin · The First Affiliated Hospital of Xinjiang Medical University, Ürümqi · Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology, Wuhan · Wuhan Union Hospital Tongji Medical College, Huazhong University of Science and Technology, Wuhan · Wuxi People's Hospital, Wuxi · Xi'an International Medical Center Hospital, Xi'an · The Second Affiliated Hospital of Xi'an Jiao Tong University, Xi'an · General Hospital of Ningxia Medical University, Yinchuan · Affiliated Hospital of Guangdong Medical University, Zhanjiang · Henan Provincial Chest Hospital, Zhengzhou · Affiliated Hospital of Zunyi Medical University, Zunyi

  Registry updated 2026-11-05

• NCT07090499

  A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

  Trial Treatment · Phase 1 · Pfizer

  Hunan Cancer Hospital, Changsha

  Registry updated 2026-11-05

• NCT07144280

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  Trial Treatment · Phase 3 · Pfizer

  Beijing Cancer Hospital, Beijing · Beijing Friendship Hospital Affiliate of Capital University, Beijing · Hunan Cancer Hospital, Changsha · The First People's Hospital Of Changzhou, Changzhou · West China Hospital，Sichuan University, Chengdu · Chongqing University Cancer Hospital, Chongqing · Fujian Cancer Hospital, Fuzhou · Southern Medical University Nanfang Hospital, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Anhui Provincial Hospital, Hefei · The First Affiliated Hospital of Anhui Medical University, Hefei · Jinan Central Hospital, Jinan · Yunnan Province Cancer Hospital, Kunming · The First Affiliated Hospital of NanChang University, Nanchang · Jiangsu Province Hospital, Nanjing · Guangxi Medical University Affiliated Tumor Hospital, Nanning · Shanghai East Hospital, Shanghai · Fudan University Shanghai Cancer Center, Shanghai · Taizhou Hospital of Zhejiang Province, Taizhou · Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · The Affiliated Hospital of Xuzhou Medical College, Xuzhou · Henan Cancer Hospital, Zhengzhou

  Registry updated 2026-11-05

• NCT07361497

  A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

  Trial Treatment · Phase 3 · Bristol-Myers Squibb

  Beijing Cancer Hospital, Beijing · Changsha · West China Hospital，Sichuan University, Chengdu · Sichuan Cancer Hospital, Chengdu · Chongqing University Cancer Hospital, Chongqing · Fujian Cancer Hospital, Fuzhou · Sun Yat-sen University Cancer Center, Guangzhou · The second Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou · Zhejiang Cancer Hospital, Hangzhou · Qilu Hospital of Shandong University, Jinan · Shandong Cancer Hospital, Jinan · Jingzhou First People's Hospital, Jingzhou · Taizhou Hospital of Zhejiang Province, Linhai · The Second Affiliated Hospital of Nanchang University, Nanchang · Shanghai · Shanghai Shi · Cancer Hospital of Shantou University Medical College, Shantou · Shenyang · Peking University Shenzhen Hospital, Shenzhen · The First Affiliated Hospital of Soochow University, Suzhou · Shanxi Cancer hospital, Taiyuan · The Central Hospital of Wuhan, Wuhan · Wuhan · The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Henan Cancer Hospital, Zhengzhou

  Registry updated 2026-11-05

• NCT07880353

  Real-World Outcomes of Sevabertinib in HER2-Mutant Advanced NSCLC: A Bidirectional Cohort Study

  Research · Ruijin Hospital

  Ruijin-Hainan Hospital, Shanghai Jiao Tong University School of Medicine (Hainan Boao Research Hospital), Qionghai

  Registry updated 2026-11-05

• NCT05579366

  Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  Trial Treatment · Phase 1/2 · Genmab

  Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital - Phase 1, Changsha · Hunan Cancer Hospital - Thoracic Medicine Dept II, Changsha · Obstetrics & Gynecology Hospital of Fudan University, Chengdu · Chongqing University Cancer Hospital, Chongqing · Fujian Cancer Hospital, Fujian · Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong · Zhejiang Cancer Hospital, Hangzhou · Second Affiliated Hospital of Zhengzhou University, Henan · Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei · Jiangxi maternal and child health hospital, Nanchang · Shanghai East Hospital, Shanghai · Fudan University Shanghai Cancer Center- Phase 1, Shanghai · Fudan University Shanghai Cancer Center - Gynecologic Oncology, Shanghai · Sichuan Cancer Hospital, Shanghai · Second Hospital of Shanxi Medical University, Shanxi · Shanxi Cancer Hospital, Shanxi · Liaoning Cancer Hospital & Institute, Shengyang · Tianjin Cancer Hospital, Tianjin

  Registry updated 2026-11-04

• NCT06119581

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Cancer Hospital Chinese Academy of Medical Science, Beijing · Beijing Cancer Hospital, Beijing · Jilin Province Tumor Hospital, Changchun · Hunan Cancer Hospital, Changsha · The First People's Hospital Of Changzhou, Changzhou · Sichuan Cancer Hospital, Chengdu · West China Hospital，Sichuan University, Chengdu · Fujian Cancer Hospital, Fuzhou · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Hainan General Hospital, Haikou · The First Affiliated Hospital, Zhejiang University, Hangzhou · Zhejiang Cancer Hospital, Hangzhou · Sir Run Run Shaw Hospital, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Jinan Central Hospital, Jinan · Shandong Cancer Hospital, Jinan · Taizhou Hospital of Zhejiang Province, Linhai · LinYi Cancer Hospital, Linyi · Liuzhou People's Hospital, Liuzhou · The First Affiliated Hospital of NanChang University, Nanchang · Nanjing First Hospital, Nanjing · Shanghai Chest Hospital, Shanghai · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Xinjiang Medical University Cancer Hospital - Urumqi, Ürümqi · Renmin Hospital of Wuhan University, Wuhan · Wuhan Union Hospital, Wuhan · Tongji Hospital Tongji Medical,Science & Technology, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Xiangyang Central Hospital, Xiangyang · Yichang Central People's Hospital, Yichang · Affiliated Hospital of Guangdong Medical University, Zhanjiang · Zhuzhou Central Hospital, Zhuzhou

  Registry updated 2026-11-04

• NCT06452277

  A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

  Trial Treatment · Phase 3 · Bayer

  The People's Liberation Army General Hospital (Beijing 301 Hospital), Beijing · Beijing Hospital, Beijing · Beijing chest hospital, Capital Medical University, Beijing · Beijing Cancer Hospital - Oncology Department, Beijing · Cancer Hospital, Chinese Academy of Medical Sciences, Beijing · Jilin Cancer Hospital, Changchun · Hunan Cancer Hospital - Oncology Department, Changsha · West China Hospital，Sichuan University, Chengdu · University of Electronic Science & Technology of China - Sichuan Cancer Hospital & Institute (Sichuan Provincial Tumor Hospital), Chengdu · Fujian Cancer Hospital, Fuzhou · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Zhejiang Cancer Hospital, Hangzhou · Sir Run Run Shaw Hospital, Zhejiang Univ. School of Medicine - Oncology Department, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Shandong University - Shandong Cancer Hospital, Jinan · LinYi Cancer Hospital (Linyi Tumor Hospital), Linyi · Jiangsu Provincial People's Hospital - The First Affiliated Hospital of Nanjing Medical University, Nanjing · Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing · Guangxi Medical University (GXMU) - Affiliated Tumor Hospital, Nanning · ShangHai Chest Hospital ShangHai JiaoTong University, Shanghai · Zhongshan Hospital,Fudan University, Shanghai · Zhejiang University School of Medicine - Taizhou Hospital of Zhejiang Province, Taizhou · Hubei Cancer Hospital, Wuhan · Union Hospi, Tongji Med College, Huazhong Univ. Scien&Tech, Wuhan · Xiamen University - The First Affiliated Hospital, Xiamen

  Registry updated 2026-11-04

• NCT06465069

  A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  Trial Treatment · Phase 1 · Eli Lilly and Company

  Beijing Cancer Hospital, Beijing · Sun Yat-sen University Cancer Center, Guangzhou · Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

  Registry updated 2026-11-04

• NCT06890598

  Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

  Trial Treatment · Phase 3 · Eli Lilly and Company

  Anyang Cancer Hospital, Anyang · Cancer Hospital Chinese Academy of Medical Science, Beijing · Beijing Cancer Hospital, Beijing · Peking University People's Hospital, Beijing · China-Japan Friendship Hospital, Beijing · Jilin Province Tumor Hospital, Changchun · Hunan Cancer Hospital, Changsha · Xiangya Hospital Central South University, Changsha · The Third People's Hospital of Chengdu (CDTPH), Chengdu · West China Hospital，Sichuan University, Chengdu · Sichuan Cancer Hospital, Chengdu · The Second Affiliated Hospital Chongqing Medical University, Chongqing · The First People's Hospital of Foshan, Foshan · The First Affiliated Hospital of Guangzhou Medical University, Guangzhou · Guangdong Provincial People's Hospital, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Zhejiang Provincial People's Hospital, Hangzhou · Zhejiang Cancer Hospital, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Shandong Cancer Hospital, Jinan · Jinan Central Hospital, Jinan · Taizhou Hospital of Zhejiang Province, Linhai · Liuzhou People's Hospital, Liuzhou · The First Affiliated Hospital of Henan University of Science &Technology, Luoyang · Guangxi Medical University Affiliated Tumor Hospital, Nanning · Fudan University Shanghai Cancer Center, Shanghai · Shanghai Chest Hospital, Shanghai · Cancer Hospital of Shantou University Medical College, Shantou · Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center, Shenzhen · Shenzhen People's Hospital, Shenzhen · The First Affiliated Hospital of Soochow University, Suzhou · Tianjin Medical University Cancer Institute & Hospital, Tianjin · Tongji Hospital Tongji Medical,Science & Technology, Wuhan · Hubei Cancer Hospital, Wuhan · The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an · Zhongshan Peoples Hospital, Zhongshan

  Registry updated 2026-11-04

• NCT07492680

  A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

  Trial Treatment · Phase 2 · Bristol-Myers Squibb

  Beijing · Chongqing University Cancer Hospital, Chongqing · Guangzhou · Shanghai GoBroad Cancer Hospital China Pharmaceutical University, Shanghai · Fudan University Shanghai Cancer Center, Shanghai · The First Affiliated Hospital of Henan Medical University, Xinxiang

  Registry updated 2026-11-04

• NCT07709585

  Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients

  Trial Treatment · Phase 2 · Guangzhou University of Traditional Chinese Medicine

  Guangdong Provincial Hospital of Chinese Medicine, Guangzhou · Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou

  Registry updated 2026-11-04

• NCT07909863

  Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer

  Trial Treatment · Phase 2 · Tianjin Medical University Cancer Institute and Hospital

  Tianjin Medical University Cancer Institute and Hospital, Tianjin

  Registry updated 2026-11-04

• NCT07914764

  68Ga-labeled Cholecystokinin Receptor (CCK2R) Targeted Molecular Probes in Early Tumor Diagnosis

  Research · Nanjing First Hospital, Nanjing Medical University

  Nanjing First Hospital, Nanjing

  Registry updated 2026-11-04

• NCT07915193

  Application of Generative Artificial Intelligence in Perioperative Personalized Rehabilitation for Older Adults With Lung Cancer

  Trial Treatment · Peking University Cancer Hospital & Institute

  Peking University Cancer Hospital, Beijing

  Registry updated 2026-11-04

• NCT07916129

  Single-center Transformational Study on Feasibility and Efficacy of Respiratory Motion Management Using Novel Position Fixation Device for Lung Cancer Patients Undergoing Stereotactic Body Radiation Therapy(2023 No.358 Project)

  Trial Treatment · Tianjin Medical University Cancer Institute and Hospital

  Tianjin Medical University Cancer Institute and Hospital, Tianjin

  Registry updated 2026-11-04

• NCT03340506

  Dabrafenib and/or Trametinib Rollover Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Beijing

  Registry updated 2026-11-03

• NCT05498428

  A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  Trial Treatment · Phase 2 · Janssen Research & Development, LLC

  Affiliated Hospital of Hebei University, Baoding · Jilin Cancer Hospital, Changchun · West China Hospital，Sichuan University, Chengdu · Sichuan Cancer Hospital, Chengdu · The First Affiliated Hospital of PLA Army Medical University, Chongqing · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou · The First Affiliated Hospital Zhejiang University College of Medicine, Hangzhou · Harbin Medical University Cancer Hospital, Harbin · Huizhou Municipal Central Hospital, Huizhou · Liuzhou People's Hospital, Liuzhou · Fudan University Shanghai Cancer Center, Shanghai · Tianjin Medical University General Hospital, Tianjin · The First Affiliated Hospital of Wenzhou Medical University, Wenzhou · Union Hospital Tongji Medical College of Huazhong University of Science and Technology, Wuhan · Hospital of Jiangnan University, Wuxi · The First Affiliated Hospital of Xian Jiaotong University, Xi'an · Yantai Yuhuangding Hospital, Yantai

  Registry updated 2026-11-03

All Lung cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error